The UK and Germany are continuing to strengthen their long-standing scientific partnership with a significant new investment package to accelerate quantum innovation.
The University of Oxford has launched a £118M AI vaccine research programme, CoI-AI, with the Ellison Institute, aiming to combat antibiotic resistance through human challenge trials.
Accuro offers speech-to-text transcription services designed to alleviate the administrative burden faced by clinicians in healthcare settings. Here, they explain the advantages of the company’s Ambient Voice Technology (AVT), particularly through the use of an Ambient Scribe.
A new multi-omics AI model combines cfDNA and cfRNA to predict preterm birth risk with nearly 90% accuracy, offering promising insights for maternal health.
If technology seeks to transform oncology practice, it must solve three big needs: data, training and trust. Annemiek Snoeckx, Co-Chair of the Digital Health Network at the European Cancer Organisation, explains.
Surabhi Srivastava, Commercial Head UK and EU at Qure.ai, discusses how integrating artificial intelligence can reduce chest X-ray reporting times and accelerate early lung cancer diagnosis.
Europe is seeing a surge in AI-powered healthcare innovation, with startups leading the charge in transforming patient care, diagnostics, and treatment.
Yasir Ahmad and Moneeza Baig from the College of Electrical and Mechanical Engineering unpack AI in academia, arguing that it is time to de-learn and re-learn.
Researchers have shown that AI can detect early laryngeal cancer and related lesions from voice recordings, offering a simple, non-invasive screening option.
A new artificial intelligence tool is helping researchers tackle some challenges within fusion energy by protecting the inside of fusion reactors from the intense heat of plasma.
Researchers from the University of Zurich have developed an AI-driven gene editing method that improves DNA repair predictions, enabling more accurate and safer genome modifications.
King's College London researchers develop a minimally invasive under-the-skin electrode that allows continuous, real-world tracking of epilepsy seizures, improving diagnosis and treatment options.
